진료 정보 교환(HIE) 시장 : 용도별, 구성요소별, 운영 모델별, 설정 유형별, 솔루션별, 유형별, 지역별 - 예측(-2031년)

The healthcare information exchange (HIE) market is projected to reach USD 3.40 billion by 2031 from USD 2.09 billion in 2026, at a CAGR of 10.3% from 2026 to 2031. This market expansion is primarily driven by the need for seamless exchanges of patient health information within the healthcare environment. As healthcare delivery becomes increasingly fragmented, with patients seeking medical attention from multiple providers, there is a growing demand for coordinated and consistent services.

Additionally, regulatory policies, government initiatives, and programs designed to promote interoperability and information exchange have contributed to the adoption of HIE solutions. Notable examples of these initiatives include the MACRA legislation and the Promoting Interoperability program (formerly known as Meaningful Use), which offer incentives for adopting electronic health record (EHR) technologies that incorporate HIE capabilities. However, the market faces challenges due to the lack of standardized data formats and interoperability between incompatible systems.

"By solution, the platform-centric HIE solutions segment is expected to witness the highest growth during the forecast period."

The health information exchange (HIE) market is divided into three segments: portal-centric, messaging-centric, and platform-centric. Among these, the platform-centric solutions segment is expected to grow the fastest. This growth is driven by an increasing need for cloud-enabled ecosystems that facilitate data sharing and interoperability among healthcare stakeholders. Platform-centric solutions encompass integrated platforms that combine data exchange, analytics, and applications, enhancing both operational efficiency and decision-making. One example of a company in this space is Veradigm, which offers data platforms that promote interoperability using FHIR standards and enable real-time data exchange among various industry stakeholders.

"By application, the web portal development segment held the largest market share in 2025."

The health information exchange market is segmented based on application into web portal development, workflow management, secure messaging, internal interfacing, and other applications. The web portal development segment held the largest market share in 2025 due to its crucial role in providing easy access to patient health data for both medical professionals and patients. Web portals serve as central hubs where users can access, share, and organize their health data, including test results, drug profiles, and other health-related information. A key factor contributing to the success of the web portal development category is its widespread use by hospitals of all sizes and types. This accessibility allows doctors to quickly obtain patient health data from various sources, including electronic health record (EHR) systems, lab data, and imaging systems.

"By end user, the healthcare providers segment is expected to register the highest growth in the health information exchange market during the forecast period."

The health information exchange (HIE) market is segmented by end user into three categories: healthcare providers, healthcare payers, and pharmacies. The healthcare providers segment is experiencing the fastest growth due to its vital role in delivering care and managing patient medical records. In the US, healthcare providers are increasingly focusing on implementing HIE solutions to enhance care coordination and ensure regulatory compliance. For example, in June 2023, the prominent healthcare provider, Mayo Clinic, announced a strategic alliance with Microsoft to launch the Azure Health Data Services platform. This platform is equipped with HIE functionality, enabling seamless data exchange across the organization's facilities.

"The APAC is estimated to register the highest CAGR during the forecast period."

This report segments the healthcare information exchange (HIE) market into several regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The HIE market in the Asia Pacific (APAC) region is projected to experience the highest compound annual growth rate (CAGR) during the forecast period. This growth is largely due to significant transformations in the APAC healthcare landscape, characterized by increased digitization, urbanization, and higher healthcare spending. As more healthcare organizations adopt technological innovations to enhance their services, the necessity for data exchange and interoperability is becoming more evident. Additionally, government policies and programs aimed at promoting the use of IT solutions and interoperability in the healthcare sector are further driving the HIE market in the APAC region. Countries such as China, Japan, South Korea, and Australia are leading the charge by encouraging the adoption of e-health technologies through the establishment of national health IT strategies and interoperability standards. These initiatives facilitate the exchange of electronic health records (EHRs) and other critical health information among healthcare institutions. Noteworthy examples include China's Healthy China 2030 initiative and Australia's My Health Record program.

Breakdown of Supply-side Primary Interviews, by Company Type, Designation, and Region:

• By Company Type: Tier 1 (40%), Tier 2 (35%), and Tier 3 (25%)
• By Designation: C-level Executives (35%), Directors (45%), and Others (20%)
• By Region: North America (55%), Europe (20%), Asia Pacific (15%), Latin America (5%), and the Middle East & Africa (5%)

List of Companies Profiled in the Report

• Epic Systems Corporation (US)
• Oracle (US)
• InterSystems Corporation (US)
• Veradigm LLC (US)
• Medical Information Technology, Inc. (US)
• Health Catalyst (US)
• Chetu Inc. (US)
• Meditab (US)
• Siemens Healthineers (Germany)
• Deloitte (UK)
• Dreamsoft4u (US)
• NCrypted Technologies. (India)
• Glorium Technologies (US)
• Daffodil Unthinkable Software Corporation (US)
• eClinicalWorks (US)
• NXGN Management, LLC (US)
• Orion Health (New Zealand)
• Kellton (India)
• Telstra Health (Australia)
• CGI Inc. (Canada)
• Excelicare (US)
• Octal IT Solution (US)
• Andersen (Poland)
• SISGAIN (India)
• Cleverdev Software (US)
• OSP Labs (US)

Research Coverage

This report analyzes the healthcare information exchange market based on various factors, including type, setup type, implementation model, solution, component, application, end user, and region. It examines the drivers, opportunities, and challenges that influence market growth. Additionally, the report assesses the opportunities and challenges for stakeholders and details the competitive landscape for market leaders. The study also explores micro markets, focusing on their growth trends, prospects, and contributions to the overall health information exchange market. Furthermore, it provides revenue forecasts for the market segments across five major regions.

Reasons to Buy the Report

This report also includes.

• Analysis of key drivers (rising adoption of EHR/EMR solutions, growing focus on patient-centric care delivery, need to curtail escalating healthcare costs, government initiatives and regulations to enhance patient care and safety, and rising investments from government and private institutions), restraints (need for significant investments in infrastructure development and high cost of deployment, lack of true interoperability solutions, and use of outdated legacy systems), opportunities (improving healthcare infrastructure in emerging markets and advancements in software technology for real-time data exchange), and challenges (patient data security and privacy concerns in the healthcare industry, increasing complexity due to lack of consistent data, and shortage of skilled healthcare IT professionals) are contributing the growth of the healthcare information exchange market.
• Product Development/Innovation: Detailed insights on upcoming trends, research & development activities, and new software launches in the healthcare information exchange market.
• Market Development: Comprehensive information on the lucrative emerging markets, components, applications, end users, and regions.
• Market Diversification: Exhaustive information about the software portfolios, growing geographies, recent developments, and investments in the healthcare information exchange market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, company evaluation quadrant, and capabilities of leading players in the global healthcare information exchange market.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 STUDY SCOPE
  • 1.3.1 MARKET SEGMENTATION AND REGIONAL SCOPE
  • 1.3.2 INCLUSIONS & EXCLUSIONS OF STUDY
  • 1.3.3 YEARS CONSIDERED
  • 1.3.4 CURRENCY CONSIDERED
• 1.4 STAKEHOLDERS
• 1.5 SUMMARY OF CHANGES

2 EXECUTIVE SUMMARY

• 2.1 KEY INSIGHTS AND MARKET HIGHLIGHTS
• 2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS
• 2.3 DISRUPTIVE TRENDS SHAPING HEALTHCARE INFORMATION EXCHANGE MARKET
• 2.4 HIGH-GROWTH SEGMENTS
• 2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST

3 PREMIUM INSIGHTS

• 3.1 ATTRACTIVE OPPORTUNITIES FOR HEALTHCARE INFORMATION EXCHANGE MARKET
• 3.2 NORTH AMERICA HEALTH INFORMATION EXCHANGE MARKET, BY END USER AND COUNTRY
• 3.3 HEALTHCARE INFORMATION EXCHANGE MARKET, BY COUNTRY

4 MARKET OVERVIEW

• 4.1 INTRODUCTION
• 4.2 MARKET DYNAMICS
  • 4.2.1 DRIVERS
    • 4.2.1.1 Rising adoption of EHR/EMR solutions
    • 4.2.1.2 Growing focus on patient-centric care delivery
    • 4.2.1.3 Need to curtail escalating healthcare costs
    • 4.2.1.4 Government initiatives and regulations to enhance patient care & safety
    • 4.2.1.5 Rising investments from government & private institutes
  • 4.2.2 RESTRAINTS
    • 4.2.2.1 Need for significant investments in infrastructure development and high cost of deployment
    • 4.2.2.2 Lack of true interoperability solutions
    • 4.2.2.3 Use of outdated legacy systems
  • 4.2.3 OPPORTUNITIES
    • 4.2.3.1 Improving healthcare infrastructure in emerging markets
    • 4.2.3.2 Advancements in software technology for real-time data exchange
  • 4.2.4 CHALLENGES
    • 4.2.4.1 Patient data security and privacy concerns in healthcare industry
    • 4.2.4.2 Increasing complexity due to lack of consistent data
    • 4.2.4.3 Shortage of skilled healthcare IT professionals
• 4.3 UNMET NEEDS AND WHITE SPACES
• 4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
• 4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS

5 INDUSTRY TRENDS

• 5.1 PORTER'S FIVE FORCES ANALYSIS
  • 5.1.1 BARGAINING POWER OF SUPPLIERS (MODERATE)
  • 5.1.2 BARGAINING POWER OF BUYERS (HIGH)
  • 5.1.3 THREAT OF SUBSTITUTES (LOW TO MODERATE)
  • 5.1.4 THREAT OF NEW ENTRANTS (MODERATE)
  • 5.1.5 INTENSITY OF COMPETITIVE RIVALRY (HIGH)
• 5.2 MACROECONOMIC INDICATORS
  • 5.2.1 GDP TRENDS AND FORECAST
  • 5.2.2 TRENDS IN GLOBAL HEALTHCARE IT INDUSTRY
• 5.3 VALUE CHAIN ANALYSIS
• 5.4 ECOSYSTEM ANALYSIS
• 5.5 PRICING ANALYSIS
  • 5.5.1 INDICATIVE PRICING ANALYSIS OF KEY PLAYERS, BY TYPE, 2025
  • 5.5.2 INDICATIVE PRICING ANALYSIS, BY REGION, 2025
• 5.6 KEY CONFERENCES AND EVENTS, 2026-2027
• 5.7 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
• 5.8 INVESTMENT AND FUNDING SCENARIO
• 5.9 CASE STUDY ANALYSIS
  • 5.9.1 INTEROPERABILITY SOLUTIONS TO LEVERAGE CLINICAL WORKFLOWS
  • 5.9.2 SHARING CLINICAL INFORMATION TO SET FOUNDATION OF EFFICIENT AND EFFECTIVE HEALTHCARE DELIVERY
  • 5.9.3 SUPPORTING HEALTH INFORMATION EXCHANGE ACCESS
• 5.10 IMPACT OF 2025 US TARIFF
  • 5.10.1 KEY TARIFF RATES
  • 5.10.2 PRICE IMPACT ANALYSIS
  • 5.10.3 IMPACT ON COUNTRY/REGION
    • 5.10.3.1 US
    • 5.10.3.2 Europe
    • 5.10.3.3 Asia Pacific
  • 5.10.4 IMPACT ON END-USE INDUSTRY
    • 5.10.4.1 Healthcare Providers
    • 5.10.4.2 Healthcare Payers
    • 5.10.4.3 Pharmacies
    • 5.10.4.4 Laboratories

6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS

• 6.1 KEY TECHNOLOGIES
  • 6.1.1 ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING
  • 6.1.2 BLOCKCHAIN
• 6.2 COMPLEMENTARY TECHNOLOGIES
  • 6.2.1 INTERNET OF THINGS
  • 6.2.2 DATA ANALYTICS AND BUSINESS INTELLIGENCE TOOLS
• 6.3 ADJACENT TECHNOLOGIES
  • 6.3.1 CLOUD COMPUTING
• 6.4 TECHNOLOGY/PRODUCT ROADMAP
• 6.5 PATENT ANALYSIS
  • 6.5.1 PATENT PUBLICATION TRENDS FOR THE HEALTHCARE INFORMATION EXCHANGE MARKET
  • 6.5.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
• 6.6 FUTURE APPLICATIONS
  • 6.6.1 AI-DRIVEN PREDICTIVE CARE COORDINATION AND DECISION SUPPORT
  • 6.6.2 UNIFIED LONGITUDINAL PATIENT RECORDS AND CONSUMER ACCESS
  • 6.6.3 REAL-TIME PUBLIC HEALTH SURVEILLANCE AND EMERGENCY RESPONSE
  • 6.6.4 BLOCKCHAIN-ENABLED TRUSTED DATA EXCHANGE
  • 6.6.5 VALUE-BASED CARE, PAYER INTEGRATION, AND REVENUE OPTIMIZATION
  • 6.6.6 INTEGRATION WITH REMOTE MONITORING, GENOMICS, AND PRECISION MEDICINE
• 6.7 IMPACT OF AI/GEN AI
  • 6.7.1 MARKET POTENTIAL OF AI/GEN AI
  • 6.7.2 CASE STUDIES RELATED TO AI/GEN AI IMPLEMENTATION
    • 6.7.2.1 AI-Driven Clinical Summarization and Interoperability Intelligence at InterSystems HealthShare
  • 6.7.3 IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS
    • 6.7.3.1 Healthcare data analytics and AI-driven interoperability platforms
    • 6.7.3.2 Digital health platforms, integration, and regulatory infrastructure
    • 6.7.3.3 Clinical care, payer operations, and personalized healthcare delivery
  • 6.7.4 USER READINESS AND IMPACT ASSESSMENT
    • 6.7.4.1 User readiness
      • 6.7.4.1.1 User A: Healthcare Providers (Hospitals, Clinics, Long-Term Care Centers, Other Providers)
      • 6.7.4.1.2 User B: Healthcare Payers
    • 6.7.4.2 Impact assessment
      • 6.7.4.2.1 User A: Healthcare Providers
        • 6.7.4.2.1.1 Implementation
        • 6.7.4.2.1.2 Impact
      • 6.7.4.2.2 User B: Healthcare Payers
        • 6.7.4.2.2.1 Implementation
        • 6.7.4.2.2.2 Impact

7 REGULATORY LANDSCAPE

• 7.1 REGIONAL REGULATIONS AND COMPLIANCE
  • 7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 7.1.2 INDUSTRY STANDARDS

8 CUSTOMER LANDSCAPE AND BUYER BEHAVIOR

• 8.1 DECISION-MAKING PROCESS
• 8.2 KEY STAKEHOLDERS IN BUYING PROCESS AND THEIR EVALUATION CRITERIA
  • 8.2.1 KEY STAKEHOLDERS INVOLVED IN BUYING PROCESS
  • 8.2.2 BUYING CRITERIA
• 8.3 ADOPTION BARRIERS AND INTERNAL CHALLENGES
• 8.4 UNMET NEEDS FROM END-USE INDUSTRIES
  • 8.4.1 UNMET NEEDS
  • 8.4.2 END-USER EXPECTATIONS
• 8.5 MARKET PROFITABILITY

9 HEALTH INFORMATION EXCHANGE MARKET, BY APPLICATION

• 9.1 INTRODUCTION
• 9.2 WEB PORTAL DEVELOPMENT
  • 9.2.1 LARGE NUMBER OF PHYSICIANS OPTING FOR ELECTRONIC MEDICAL RECORDS TO DRIVE MARKET
• 9.3 WORKFLOW MANAGEMENT
  • 9.3.1 BETTER DECISION-MAKING FOR ENHANCED PATIENT CARE TO PROPEL MARKET
• 9.4 SECURE MESSAGING
  • 9.4.1 ABILITY TO PROVIDE SECURE COMMUNICATION WITHIN AND OUTSIDE CARE NETWORK TO SUPPORT MARKET GROWTH
• 9.5 INTERNAL INTERFACING
  • 9.5.1 FASTEST-GROWING APPLICATION SEGMENT DURING FORECAST PERIOD
• 9.6 TRANSACTION MONITORING
  • 9.6.1 SECURE, EFFICIENT, AND COMPLIANT EXCHANGE OF HEALTH DATA-KEY FACTORS DRIVING MARKET GROWTH

10 HEALTH INFORMATION EXCHANGE MARKET, BY COMPONENT

• 10.1 INTRODUCTION
• 10.2 CLINICAL DATA REPOSITORY
  • 10.2.1 EASY ACCESS TO DATA ACROSS EMR DOMAIN TO SUPPORT MARKET GROWTH
• 10.3 ENTERPRISE MASTER PERSON INDEX
  • 10.3.1 EMPI TO DOMINATE HIE MARKET DURING FORECAST PERIOD
• 10.4 RECORD LOCATOR SERVICE
  • 10.4.1 RLS TO REGISTER HIGHEST GROWTH RATE
• 10.5 HEALTHCARE PROVIDER DIRECTORY
  • 10.5.1 COMPREHENSIVE DATABASE AND RELIABILITY OF HPD TO DRIVE MARKET

11 HEALTH INFORMATION EXCHANGE MARKET, BY IMPLEMENTATION MODEL

• 11.1 INTRODUCTION
• 11.2 HYBRID MODEL
  • 11.2.1 HYBRID HIE MODELS TO HOLD LARGEST MARKET SHARE
• 11.3 CENTRALIZED MODEL
  • 11.3.1 PRIVACY AND SECURITY CONCERNS TO HINDER ADOPTION OF CENTRALIZED HIE
• 11.4 DECENTRALIZED/FEDERATED
  • 11.4.1 REAL-TIME UPDATED DATA AVAILABILITY AND INCREASED SECURITY TO DRIVE ADOPTION

12 HEALTH INFORMATION EXCHANGE MARKET, BY SETUP TYPE

• 12.1 INTRODUCTION
• 12.2 PRIVATE
  • 12.2.1 RISING MANDATES FOR INCENTIVE PROGRAMS TO DRIVE MARKET
• 12.3 PUBLIC
  • 12.3.1 GROWING GOVERNMENT FUNDING TO SUPPORT MARKET GROWTH

13 HEALTH INFORMATION EXCHANGE MARKET, BY SOLUTION

• 13.1 INTRODUCTION
• 13.2 PORTAL-CENTRIC HIE SOLUTIONS
  • 13.2.1 PORTAL-CENTRIC SOLUTIONS TO DOMINATE HEALTH INFORMATION EXCHANGE MARKET DURING FORECAST PERIOD
• 13.3 MESSAGING-CENTRIC HIE SOLUTIONS
  • 13.3.1 HIGH PERFORMANCE AND RELIABILITY OF MESSAGING-CENTRIC SOLUTIONS TO DRIVE MARKET
• 13.4 PLATFORM-CENTRIC HIE SOLUTIONS
  • 13.4.1 PLATFORM-CENTRIC SOLUTIONS TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD

14 HEALTH INFORMATION EXCHANGE MARKET, BY TYPE

• 14.1 INTRODUCTION
• 14.2 DIRECTED EXCHANGE
  • 14.2.1 DIRECTED EXCHANGE SEGMENT TO COMMAND LARGEST SHARE OF HEALTH INFORMATION EXCHANGE MARKET
• 14.3 QUERY-BASED EXCHANGE
  • 14.3.1 QUERY-BASED EXCHANGE SEGMENT TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
• 14.4 CONSUMER-MEDIATED EXCHANGE
  • 14.4.1 GROWING PATIENT-PHYSICIAN INTERACTION TO DRIVE POPULARITY OF CONSUMER-MEDIATED SOLUTIONS

15 HEALTH INFORMATION EXCHANGE MARKET, BY REGION

• 15.1 INTRODUCTION
• 15.2 NORTH AMERICA
  • 15.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 15.2.2 US
    • 15.2.2.1 Layered interoperability and stringent certification requirements to drive market
  • 15.2.3 CANADA
    • 15.2.3.1 Government initiatives to support HIE adoption in Canada
• 15.3 EUROPE
  • 15.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
  • 15.3.2 GERMANY
    • 15.3.2.1 Landmark Health Data Use Act and EHDS alignment catalyze research-grade HIE platforms
  • 15.3.3 UK
    • 15.3.3.1 Growing patient volumes to drive market
  • 15.3.4 FRANCE
    • 15.3.4.1 Favorable government initiatives to drive market
  • 15.3.5 ITALY
    • 15.3.5.1 PNRR-funded FSE 2.0 drives national interoperability and cross-regional HIE unification
  • 15.3.6 SPAIN
    • 15.3.6.1 Cross-regional HIE scale-up and national AI strategy cement digital health leadership
  • 15.3.7 REST OF EUROPE
• 15.4 ASIA PACIFIC
  • 15.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
  • 15.4.2 JAPAN
    • 15.4.2.1 Growing need to digitize patient records to drive market
  • 15.4.3 CHINA
    • 15.4.3.1 Large patient population and healthcare infrastructure improvements to drive market
  • 15.4.4 INDIA
    • 15.4.4.1 Rising need for cost-effective technologies to drive HCIT integration in India
  • 15.4.5 REST OF ASIA PACIFIC
• 15.5 LATIN AMERICA
  • 15.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
  • 15.5.2 BRAZIL
    • 15.5.2.1 RNDS formalized as national interoperability backbone with 2.8 billion clinical records
  • 15.5.3 MEXICO
    • 15.5.3.1 openEHR Adoption and IMSS digital health modernization drive national HIE platform investment
  • 15.5.4 REST OF LATIN AMERICA
• 15.6 MIDDLE EAST & AFRICA
  • 15.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
  • 15.6.2 GCC COUNTRIES
    • 15.6.2.1 Growing focus on implementing HCIT to drive market
  • 15.6.3 REST OF MIDDLE EAST & AFRICA

16 COMPETITIVE LANDSCAPE

• 16.1 OVERVIEW
• 16.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2023-2026
• 16.3 REVENUE ANALYSIS, 2021-2025
• 16.4 MARKET SHARE ANALYSIS, 2025
• 16.5 BRAND/SOFTWARE COMPARISON
• 16.6 COMPANY VALUATION & FINANCIAL METRICS
• 16.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
  • 16.7.1 STARS
  • 16.7.2 EMERGING LEADERS
  • 16.7.3 PERVASIVE PLAYERS
  • 16.7.4 PARTICIPANTS
  • 16.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
    • 16.7.5.1 Company footprint
    • 16.7.5.2 Region footprint
    • 16.7.5.3 Setup type footprint
    • 16.7.5.4 End user footprint
• 16.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
  • 16.8.1 PROGRESSIVE COMPANIES
  • 16.8.2 RESPONSIVE COMPANIES
  • 16.8.3 DYNAMIC COMPANIES
  • 16.8.4 STARTING BLOCKS
  • 16.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
• 16.9 COMPETITIVE SCENARIO
  • 16.9.1 PRODUCT LAUNCHES
  • 16.9.2 DEALS

17 COMPANY PROFILES

• 17.1 KEY PLAYERS
  • 17.1.1 EPIC SYSTEMS CORPORATION.
    • 17.1.1.1 Business overview
    • 17.1.1.2 Products and Services offered
    • 17.1.1.3 Recent developments
      • 17.1.1.3.1 Product launches and approvals
      • 17.1.1.3.2 Deals
    • 17.1.1.4 MnM view
      • 17.1.1.4.1 Right to win
      • 17.1.1.4.2 Strategic choices
      • 17.1.1.4.3 Weaknesses and competitive threats
  • 17.1.2 ORACLE
    • 17.1.2.1 Business overview
    • 17.1.2.2 Products and services offered
    • 17.1.2.3 Recent developments
      • 17.1.2.3.1 Product launches and approvals
      • 17.1.2.3.2 Deals
    • 17.1.2.4 MnM view
      • 17.1.2.4.1 Right to win
      • 17.1.2.4.2 Strategic choices
      • 17.1.2.4.3 Weaknesses and competitive threats
  • 17.1.3 INTERSYSTEMS CORPORATION
    • 17.1.3.1 Business overview
    • 17.1.3.2 Products and services offered
    • 17.1.3.3 Recent developments
      • 17.1.3.3.1 Product launches and approvals
      • 17.1.3.3.2 Deals
    • 17.1.3.4 MnM view
      • 17.1.3.4.1 Right to win
      • 17.1.3.4.2 Strategic choices
      • 17.1.3.4.3 Weaknesses and competitive threats
  • 17.1.4 VERADIGM LLC
    • 17.1.4.1 Business overview
    • 17.1.4.2 Products and services offered
    • 17.1.4.3 Recent developments
      • 17.1.4.3.1 Product launches and approvals
      • 17.1.4.3.2 Deals
    • 17.1.4.4 MnM view
      • 17.1.4.4.1 Right to win
      • 17.1.4.4.2 Strategic choices
      • 17.1.4.4.3 Weaknesses and competitive threats
  • 17.1.5 MEDICAL INFORMATION TECHNOLOGY, INC.
    • 17.1.5.1 Business overview
    • 17.1.5.2 Products and services offered
    • 17.1.5.3 Recent developments
      • 17.1.5.3.1 Product launches and approvals
      • 17.1.5.3.2 Deals
    • 17.1.5.4 MnM view
      • 17.1.5.4.1 Right to win
      • 17.1.5.4.2 Strategic choices
      • 17.1.5.4.3 Weaknesses and competitive threats
  • 17.1.6 HEALTH CATALYST
    • 17.1.6.1 Business overview
    • 17.1.6.2 Products and services offered
    • 17.1.6.3 Recent developments
      • 17.1.6.3.1 Deals
  • 17.1.7 KELLTON
    • 17.1.7.1 Business overview
    • 17.1.7.2 Products and services offered
    • 17.1.7.3 Recent developments
      • 17.1.7.3.1 Deal
  • 17.1.8 ECLINICALWORKS
    • 17.1.8.1 Business overview
    • 17.1.8.2 Products and services offered
    • 17.1.8.3 Recent developments
      • 17.1.8.3.1 Product launches and approvals
      • 17.1.8.3.2 Deal
  • 17.1.9 NXGN MANAGEMENT, LLC.
    • 17.1.9.1 Business overview
    • 17.1.9.2 Products and services offered
  • 17.1.10 ORION HEALTH GROUP OF COMPANIES
    • 17.1.10.1 Business overview
    • 17.1.10.2 Products and services offered
    • 17.1.10.3 Recent developments
      • 17.1.10.3.1 Deal
  • 17.1.11 CHETU INC.
    • 17.1.11.1 Business overview
    • 17.1.11.2 Products and services offered
    • 17.1.11.3 Recent developments
      • 17.1.11.3.1 Deal
  • 17.1.12 TELSTRA HEALTH (A SUBSIDIARY OF TELSTRA CORPORATION LTD.)
    • 17.1.12.1 Business overview
    • 17.1.12.2 Products and services offered
      • 17.1.12.2.1 Deal
  • 17.1.13 CGI INC.
    • 17.1.13.1 Business overview
    • 17.1.13.2 Products and services offered
    • 17.1.13.3 Recent developments
      • 17.1.13.3.1 Product launches and approvals
      • 17.1.13.3.2 Deal
  • 17.1.14 MEDITAB
    • 17.1.14.1 Business overview
    • 17.1.14.2 Products and services offered
  • 17.1.15 DREAMSOFT4U
    • 17.1.15.1 Business overview
    • 17.1.15.2 Products and services offered
  • 17.1.16 NCRYPTED TECHNOLOGIES
    • 17.1.16.1 Business overview
    • 17.1.16.2 Products and services offered
  • 17.1.17 GLORIUM TECHNOLOGIES
    • 17.1.17.1 Business overview
    • 17.1.17.2 Products and services offered
  • 17.1.18 DAFFODIL UNTHINKABLE SOFTWARE CORP.
    • 17.1.18.1 Business overview
    • 17.1.18.2 Products and services offered
  • 17.1.19 SIEMENS HEALTHINEERS AG
    • 17.1.19.1 Business overview
    • 17.1.19.2 Products and services offered
      • 17.1.19.2.1 Product launches and approvals
  • 17.1.20 DELOITTE
    • 17.1.20.1 Business overview
    • 17.1.20.2 Products and services offered
    • 17.1.20.3 Recent developments
      • 17.1.20.3.1 Deals
  • 17.1.21 EXCELICARE
    • 17.1.21.1 Business overview
    • 17.1.21.2 Products and services offered
• 17.2 OTHER PLAYERS
  • 17.2.1 OCTAL IT SOLUTION
  • 17.2.2 ANDERSEN INC.
  • 17.2.3 SISGAIN
  • 17.2.4 CLEVERDEV SOFTWARE
  • 17.2.5 OSP LABS

18 RESEARCH METHODOLOGY

• 18.1 RESEARCH DATA
  • 18.1.1 SECONDARY DATA
    • 18.1.1.1 Key data from secondary sources
  • 18.1.2 PRIMARY DATA
    • 18.1.2.1 Key data from primary sources
    • 18.1.2.2 Breakdown of primaries
    • 18.1.2.3 Insights from primary experts
• 18.2 RESEARCH METHODOLOGY DESIGN
• 18.3 MARKET SIZE ESTIMATION
• 18.4 MARKET BREAKDOWN DATA TRIANGULATION
• 18.5 MARKET SHARE ESTIMATION
• 18.6 STUDY ASSUMPTIONS
• 18.7 RESEARCH LIMITATIONS
  • 18.7.1 METHODOLOGY-RELATED LIMITATIONS
• 18.8 RISK ASSESSMENT

19 APPENDIX

• 19.1 DISCUSSION GUIDE
• 19.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 19.3 CUSTOMIZATION OPTIONS
• 19.4 RELATED REPORTS
• 19.5 AUTHOR DETAILS